1. Aizenman E, Tang LH, Reynolds IJ (1991) Effects of nicotine agonists on the NMDA receptor. Brain Res 551:355–357
2. Arneric SP, Sullivan JP, Briggs CA, Donelly-Roberts D, Anderson DJ, Raskiewicz JL, Hughes M, Cadman ED, Adams P, Garvey DS, Wasicak J, Williams M (1994) (S)-3-methyl-5-(1-Methyl-2-pyrrolidinyl) isoxazole (ABT-418): a novel cholinergic ligand with cognition enhancing and anxiolytic activity: I. In vitro characterization. J Pharmacol Exp Ther 270:310–318
3. Arneric SP, Sullivan JP, Williams M (1995) Neuronal nicotinic acetylcholine receptors. Novel targets for CNS therapeutics. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York. (in press)
4. Bättig K (1981) Smoking and the behavioral effects of nicotine. Trends Pharmacol Sci 2:145–147
5. Brioni JD, Arneric SP (1993) Nicotinic receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms. Behav Neural Biol 59:57–62